TuisNTRA • NASDAQ
add
Natera Inc
Vorige sluiting
$196,45
Dagwisseling
$193,18 - $202,00
Jaarwisseling
$123,62 - $203,23
Markkapitalisasie
27,44 mjd USD
Gemiddelde volume
1,20 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 546,60 m | 32,24% |
Bedryfskoste | 456,98 m | 59,18% |
Netto inkomste | -100,94 m | -169,43% |
Netto winsgrens | -18,47 | -103,86% |
Wins per aandeel | -0,74 | -146,67% |
EBITDA | -100,51 m | -179,30% |
Effektiewe belastingkoers | -0,27% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 1,02 mjd | 14,53% |
Totale bates | 1,76 mjd | 15,83% |
Totale aanspreeklikheid | 510,88 m | -24,92% |
Totale ekwiteit | 1,25 mjd | — |
Uitstaande aandele | 137,25 m | — |
Prys om te bespreek | 21,56 | — |
Opbrengs op bates | -15,81% | — |
Opbrengs op kapitaal | -19,18% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -100,94 m | -169,43% |
Kontant van bedrywe | 37,57 m | 841,70% |
Kontant van beleggings | -23,90 m | 25,45% |
Kontant van finansiering | 12,58 m | 13,87% |
Netto kontantverandering | 26,25 m | 254,26% |
Beskikbare kontantvloei | 35,19 m | 434,63% |
Meer oor
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Gestig
01 Jan. 2004
Hoofkwartier
Webwerf
Werknemers
4 429
